Type : |
Journal |
Web link : |
http://www.ijpc.com/Abstracts/Abstract.cfm?ABS=2464 |
|
Research teams : |
Houston - M.D.Anderson Cancer Center |
Authors : |
Trissel LA, Zhang Y, Koontz SE. |
Title : |
Temozolomide Stability in Extemporaneously Compounded Oral Suspensions |
Reference : |
Int J Pharm Compound ; 10, 5: 396-399. 2006 |
|
Level of Evidence : |
|
Physical stability : |
|
Chemical stability : |
|
Other methods : |
|
Comments : |
|
List of drugs
Temozolomide
|
![Anticancer drug Anticancer drug](./images/Picto.486.jpg) |
![Factors which affect stability Factors which affect stability](./images/Picto.594.jpg) |
![excipient excipient](./images/Picto.10285.jpg) |
Povidone K30 |
![Induces Induces](./images/Picto.659.gif) |
![Enhanced stability Enhanced stability](./images/Picto.650.gif) |
![Stability in solutions Stability in solutions](./images/Picto.591.jpg) |
![plastic bottle plastic bottle](./images/Picto.10378.jpg) |
![Kapseln Kapseln](./images/Picto.10387.png) |
300 mg Temodar® |
Povidone K30 |
150 mg |
Citric acid anhydrous |
7.5 mg |
Purified water |
0.45 ml |
OraPlus® |
15 ml |
Orasweet® |
>> 30 ml |
|
4°C |
![Protect from light Protect from light](./images/Picto.526.jpg) |
60 |
![Day Day](./images/Picto.542.gif) |
|
|
![Stability in solutions Stability in solutions](./images/Picto.591.jpg) |
![plastic bottle plastic bottle](./images/Picto.10378.jpg) |
![Kapseln Kapseln](./images/Picto.10387.png) |
300 mg Temodar® |
Povidone K30 |
150 mg |
Citric acid anhydrous |
7.5 mg |
Purified water |
0.45 ml |
OraPlus® |
15 ml |
Orasweet SF ® |
>> 30 ml |
|
4°C |
![Protect from light Protect from light](./images/Picto.526.jpg) |
60 |
![Day Day](./images/Picto.542.gif) |
|
|
|
|